Dr. David Mischoulon

Academic Degree(s)

MD, PhD

 

E-Mail

DMISCHOULON@mgh.harvard.edu

 

Current Position

  • Director, Depression Clinical and Research Program, Massachusetts General Hospital
  • Associate Professor of Psychiatry, Harvard Medical School, Boston, MA

 

Professional Experience

  • 2017-present, Director, Depression Clinical and Research Program, Massachusetts General Hospital
  • 2007-2017, Director of Research, Depression Clinical and Research Program, Massachusetts General Hospital
  • 2003-2017, Director of Alternative Remedy Studies, Depression Clinical and Research Program, Massachusetts General Hospital

 

Education & Training

  • Boston University School of Medicine, MD, 1987-1994
  • Boston University School of Medicine, PhD (Biochemistry), 1987-1994

 

Awards

  • 2016, Distinguished Fellow, American Psychiatric Association and Massachusetts Psychiatric Society
  • 2015, Partners in Excellence Team Award (Telepsychiatry), Massachusetts General Hospital
  • 2006, Dr Irene Jakab Outstanding Professional Volunteer of the Year Award, Manic Depressive and Depression Association, Boston

 

Research Grants

  • Omega-3 Fatty Acids for MDD with High Inflammation: A Personalized Approach. 1UG3AT008857-01 (NIH-NCCIH); 2015-2020; PI
  • Omega-3 fatty acids for treatment of major depression: differential effects of EPA and DHA, and associated biochemical and immune parameters. NIH R01MH74085; 2006-2012; PI
  • A double-blind, placebo-controlled study of the alternative therapy S-adenosyl-l-methionine (SAMe) vs. escitalopram in major depressive disorder (MDD); NIH R01AT001638; Project Director
  • Placebo-controlled randomized study of ethyl eicosapentaenoic acid (EPA) for treatment of depression; NCCAM K23AT001129; 2001-2006; PI

 

Committee & Membership

1995-present, American Psychiatric Association (APA)

2013-present, The International Society for Nutritional Psychiatry Research (ISNPR)

2015-present, American Society of Clinical Psychopharmacology (ASCP)